SCOPUS 정보 검색 플랫폼

Hematology/Oncology Clinics of North America

Volumn 14, Issue 4, 2000, Pages 849-876

Therapeutic studies

(1) Rubinstein, Lawrence V b

a NATIONAL CANCER INSTITUTE (United States)

b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL RESEARCH; HUMAN; MULTIMODALITY CANCER THERAPY; ONCOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; STATISTICAL MODEL; TREATMENT OUTCOME;

EID: 0033887440 PISSN: 08898588 EISSN: None Source Type: Journal
DOI: 10.1016/S0889-8588(05)70315-4 Document Type: Article

Times cited : (11)

References (54)

1
- 0026109746
- Interpretation of survival data in clinical trials
- (1991) Oncology , vol.5 , pp. 104
- Anderson, J.R.¹ Crowley, J.J.² Propert, K.J.³

2
- 9444255722
- Improving the quality of reporting of randomized controlled trials: The CONSORT Statement
- (1996) JAMA , vol.276 , pp. 637
- Begg, C.¹ Cho, M.² Eastwood, S.³

3
- 0029591692
- Incorporating toxicity considerations into the design of two-stage phase II clinical trials
- (1995) Biometrics , vol.51 , pp. 1372
- Bryant, J.¹ Day, R.²

4
- 0022569778
- Potential roles for preclinical pharmacology in phase I clinical trials
- (1986) Cancer Treat Rep , vol.70 , pp. 73
- Collins, J.M.¹ Zaharko, D.S.² Dedrick, R.L.³

5
- 0030459977
- Designs for phase II trials allowing for a trade-off between response and toxicity
- (1996) Biometrics , vol.52 , pp. 1375
- Conaway, M.R.¹ Petroni, G.R.²

6
- 0000336139
- Regression models and life tables (with discussion)
- (1972) Journal of the Royal Statistical Society B , vol.34 , pp. 187
- Cox, D.R.¹

7
- 0027934302
- Interim analysis: The alpha spending function approach
- (1994) Stat Med , vol.13 , pp. 1341
- DeMets, D.L.¹ Lan, K.K.G.²

8
- 0023176979
- Confidence intervals for a binomial parameter based on multistage tests
- (1987) Biometrics , vol.43 , pp. 81
- Duffy, D.E.¹ Santner, T.J.²

9
- 0025392383
- Interim analyses in clinical trials
- (1990) Oncology , vol.4 , pp. 126
- Emerson, S.S.¹ Fleming, T.R.²

10
- 0020108590
- One sample multiple testing procedure for phase II clinical trials
- (1982) Biometrics , vol.38 , pp. 143
- Fleming, T.R.¹

11
- 0027286665
- Monitoring of clinical trials: Issues and recommendations
- (1993) Control Clin Trials , vol.14 , pp. 183
- Fleming, T.R.¹ DeMets, D.L.²

12
- 0021319092
- Considerations of monitoring and evaluating treatment effects in clinical trials
- (1984) Control Clin Trials , vol.5 , pp. 55
- Fleming, T.R.¹ Green, S.J.² Harrington, D.P.³

13
- 50549174560
- The determination of the number of patients required in a follow-up trial of a new chemotherapeutic agent
- (1961) Journal of Chronic Diseases , vol.13 , pp. 346
- Gehan, E.A.¹

14
- 0025183214
- Historical and methodological developments in clinical trials at the National Cancer Institute
- (1990) Stat Med , vol.9 , pp. 871
- Gehan, E.A.¹ Schneiderman, M.A.²

15
- 0029027770
- Some practical improvements in the continual reassessment method for phase I studies
- (1995) Stat Med , vol.14 , pp. 149
- Goodman, S.N.¹ Zahurak, M.L.² Piantadosi, S.³

16
- 0008417928
- Clinical Trials in Oncology. London, Chapman and Hall
- (1997)
- Green, S.¹ Benedetti, J.² Crowley, J.³

17
- 0022572075
- The relation of preclinical toxicology to findings in early clinical trials
- (1986) Cancer Treat Rep , vol.70 , pp. 65
- Grieshaber, C.K.¹ Marsoni, S.²

18
- 0025115074
- Common methods of analyzing response data in clinical trials
- (1990) Oncology , vol.4 , pp. 95
- Harrington, D.P.¹ Andersen, J.W.²

19
- 0020704677
- Confidence intervals for a binomial parameter following a multistage test with application to MIL-STD 105D and medical trials
- (1983) Technometrics , vol.25 , pp. 49
- Jennison, D.¹ Turnbull, B.W.²

20
- 0021323563
- Repeated confidence intervals for group sequential clinical trials
- (1984) Control Clin Trials , vol.5 , pp. 33
- Jennison, C.¹ Turnbull, B.W.²

21
- 33845382806
- Non-parametric estimation from incomplete observations
- (1958) Journal of the American Statistical Association , vol.53 , pp. 457
- Kaplan, G.¹ Meier, P.²

22
- 85031605668
- The Nation's Investment in Cancer Research. Bethesda, MD, National Cancer Institute, NIH Publication No. 99-4373
- (1999)
- Klausner, R.D.¹

23
- 0028170238
- A comparison of two phase I trial designs
- (1994) Stat Med , vol.13 , pp. 1799
- Korn, E.L.¹ Midthune, D.² Chen, T.T.³

24
- 0008512128
- Using the tolerable-dose diagram in the design of phase I combination chemotherapy trials
- (1990) J Clin Oncol , vol.8 , pp. 374
- Korn, E.L.¹ Simon, R.²

25
- 84953030627
- Stochastically curtailed tests in long-term clinical trials
- (1982) Communications in Statistics-Sequential Analysis , vol.1 , pp. 207
- Lan, K.K.G.¹ Simon, R.² Halperin, M.³

26
- 0008493339
- Research Methods in Clinical Oncology. New York, Raven Press
- (1988)
- Leventhal, B.G.¹ Wittes, R.E.²

27
- 0000573380
- Bayesian inference In Kotz S, Johnson NL (eds): Encyclopedia of Statistical Sciences, vol 1. New York, John Wiley and Sons
- (1982) , vol.1 , pp. 197
- Lindley, D.V.¹

28
- 0013886333
- Evaluation of survival data and two new rank order statistics arising in its consideration
- (1966) Cancer Chemotherapy Reports , vol.50 , pp. 163
- Mantel, N.¹

29
- 0030557614
- Design and analysis of phase II clinical trials: A review of statistical methods and guidelines for medical researchers
- (1996) International Statistical Review , vol.64 , pp. 61
- Mariani, L.¹ Marubini, E.²

30
- 0027499297
- Model-guided determination of maximum tolerated dose in phase I clinical trials: Evidence for increased precision
- (1993) J Natl Cancer Inst , vol.85 , pp. 217
- Mick, R.¹ Ratain, M.J.²

31
- 0018687930
- A multiple testing procedure for clinical trials
- (1979) Biometrics , vol.35 , pp. 549
- O'Brien, P.C.¹ Fleming, T.R.²

32
- 0025148278
- Continual reassessment method: A practical design for phase I clinical trials in cancer
- (1990) Biometrics , vol.46 , pp. 33
- O'Quigley, J.¹ Pepe, M.² Fisher, L.³

33
- 0017365573
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
- (1977) Br J Cancer , vol.35 , pp. 1
- Peto, R.¹ Pike, M.C.² Armitage, P.³

34
- 0008454376
- Clinical Trials: A Methodologic Perspective. New York, John Wiley and Sons
- (1997)
- Piantadosi, S.¹

35
- 4243264243
- Statistical review for medical journals, guidelines for authors
- In Armitage P, Colton T (eds): Encyclopedia of Biostatistics. Chichester, UK, John Wiley and Sons
- (1998) , pp. 4275
- Rubinstein, L.V.¹

36
- 0019383823
- Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation
- (1981) Journal of Chronic Diseases , vol.34 , pp. 469
- Rubinstein, L.V.¹ Gail, M.H.² Santner, T.J.³

37
- 4243261354
- Cooperative cancer trials
- In Armitage P, Colton T (eds): Encyclopedia of Biostatistics. Chichester, UK, John Wiley and Sons
- (1998) , pp. 933
- Rubinstein, L.V.¹ Ungerleider, R.²

38
- 85031608028
- Mouse to man: Statistical problems in bringing a drug to clinical trial. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, Berkeley, University of California Press
- (1967) , pp. 855
- Schneiderman, M.A.¹

39
- 0024536437
- Optimal two-stage designs for phase II clinical trials
- (1989) Control Clin Trials , vol.10 , pp. 1
- Simon, R.¹

40
- 0024691799
- Designs for efficient clinical trials
- (1989) Oncology , vol.3 , pp. 43
- Simon, R.¹

41
- 0026347876
- A decade of progress in statistical methodology for clinical trials
- (1991) Stat Med , vol.10 , pp. 1789
- Simon, R.¹

42
- 0028136211
- Some practical aspects of the interim monitoring of clinical trials
- (1994) Stat Med , vol.13 , pp. 1401
- Simon, R.¹

43
- 0002472424
- Clinical trials in cancer
- DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 5. Philadelphia, Lippincott-Raven
- (1997) , pp. 513
- Simon, R.¹

44
- 0032968433
- Bayesian design and analysis of active control clinical trials
- (1999) Biometrics , vol.55 , pp. 484
- Simon, R.¹

45
- 0030749549
- Accelerated titration designs for phase I clinical trials in oncology
- (1997) J Natl Cancer Inst , vol.89 , pp. 1138
- Simon, R.M.¹ Freidlin, B.² Rubinstein, L.V.³

46
- 0022007270
- Methodologic guidelines for reports of clinical trials
- (1985) Cancer Treat Rep , vol.69 , pp. 1
- Simon, R.¹ Wittes, R.E.²

47
- 0022312530
- Randomized phase II clinical trials
- (1985) Cancer Treat Rep , vol.69 , pp. 1375
- Simon, R.¹ Wittes, R.E.² Ellenberg, S.S.³

48
- 0031935504
- Conduct of phase I trials in children with cancer
- (1998) J Clin Oncol , vol.16 , pp. 966
- Smith, M.¹ Bernstein, M.² Bleyer, W.A.³

49
- 0024452804
- Design and analysis of phase I clinical trials
- (1989) Biometrics , vol.45 , pp. 925
- Storer, B.E.¹

50
- 0025005369
- Incorporating historical control data in planning phase II clinical trials
- (1990) Stat Med , vol.9 , pp. 215
- Thall, P.F.¹ Simon, R.²

51
- 0029177502
- Recent developments in the design of phase II clinical trials
- Thall PF (ed): Recent Advances in Clinical Trial Design and Analysis. Boston, Kluwer Academic Publishers
- (1995) , pp. 49
- Thall, P.F.¹ Simon, R.²

52
- 0030060408
- New statistical strategy for monitoring safety and efficacy in single-arm clinical trials
- (1996) J Clin Oncol , vol.14 , pp. 296
- Thall, P.F.¹ Simon, R.M.² Estey, E.H.³

53
- 0034594628
- New guidelines to evaluate the response to treatment in solid tumors (RECIST guidelines)
- (2000) J Natl Cancer Inst , vol.92 , pp. 205
- Therasse, P.¹ Arbuck, S.G.² Eisenhauer, E.A.³

54
- 0027980912
- Stopping when the experimental regimen does not appear to help
- (1994) Stat Med , vol.13 , pp. 1453
- Wieand, S.¹ Schroeder, G.² O'Fallon, J.R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.